Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation

Raloxifene HCl belongs to a class of selective estrogen receptor modulators (SERMs) which is used for the management of breast cancer. The major problem reported with raloxifene is its poor bioavailability which is only up to 2%. The main objective of the present work was to formulate raloxifene loa...

Full description

Bibliographic Details
Main Authors: Mahmood, Syed, Mandal, Uttam Kumar, Chatterjee, Bappaditya
Format: Article
Language:English
English
English
Published: Elsevier B.V. 2018
Subjects:
Online Access:http://irep.iium.edu.my/63349/
http://irep.iium.edu.my/63349/
http://irep.iium.edu.my/63349/
http://irep.iium.edu.my/63349/1/63349_Transdermal%20delivery%20of%20raloxifene%20HCl.pdf
http://irep.iium.edu.my/63349/2/63349_Transdermal%20delivery%20of%20raloxifene%20HCl_SCOPUS.pdf
http://irep.iium.edu.my/63349/13/63349_Transdermal%20delivery%20of%20raloxifene%20HCl_WOS.pdf
id iium-63349
recordtype eprints
spelling iium-633492018-06-12T07:25:23Z http://irep.iium.edu.my/63349/ Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation Mahmood, Syed Mandal, Uttam Kumar Chatterjee, Bappaditya RS192 Materia Medica-Pharmaceutical Technology Raloxifene HCl belongs to a class of selective estrogen receptor modulators (SERMs) which is used for the management of breast cancer. The major problem reported with raloxifene is its poor bioavailability which is only up to 2%. The main objective of the present work was to formulate raloxifene loaded ethosomal preparation for transdermal application and compare it with an oral formulation of the drug. Five ethosomal formulations with different concentrations of ethanol and a conventional liposomes formulation were prepared by rotary evaporation method. The prepared systems were characterised by high resolution transmission electron microscopy (HRTEM), force emission electron microscopy (FESEM), atomic force microscopy (AFM), X-ray diffraction (XRD) and 31P NMR study. All these advanced characterization study established that the ethosome formulation was well defined by its size, shape and its bilayer formation. Transdermal flux of the optimized ethosome formulation was 22.14 ± 0.83 µg/ml/cm2 which was 21 times higher when compared to the conventional liposomes. Confocal microscopy study revealed an enhanced permeation of coumarin-6 dye loaded ethosomes to much deeper layers of skin when compared with conventional liposomes. The gel was found to be pseudoplastic with elastic behaviour. In-vivo studies on rats showed a higher bioavailability of RXL (157% times) for ethosomal formulation when compared with the oral formulation. In conclusion, RXL loaded ethosomal formulation via transdermal route showed superior drug delivery properties as compared to oral formulation. © 2018 Elsevier B.V. Elsevier B.V. 2018-05-05 Article PeerReviewed application/pdf en http://irep.iium.edu.my/63349/1/63349_Transdermal%20delivery%20of%20raloxifene%20HCl.pdf application/pdf en http://irep.iium.edu.my/63349/2/63349_Transdermal%20delivery%20of%20raloxifene%20HCl_SCOPUS.pdf application/pdf en http://irep.iium.edu.my/63349/13/63349_Transdermal%20delivery%20of%20raloxifene%20HCl_WOS.pdf Mahmood, Syed and Mandal, Uttam Kumar and Chatterjee, Bappaditya (2018) Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation. International Journal of Pharmaceutics, 542 (1-2). pp. 36-46. ISSN 0378-5173 https://www.sciencedirect.com/science/article/pii/S037851731830125X?via%3Dihub https://doi.org/10.1016/j.ijpharm.2018.02.044
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
English
topic RS192 Materia Medica-Pharmaceutical Technology
spellingShingle RS192 Materia Medica-Pharmaceutical Technology
Mahmood, Syed
Mandal, Uttam Kumar
Chatterjee, Bappaditya
Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
description Raloxifene HCl belongs to a class of selective estrogen receptor modulators (SERMs) which is used for the management of breast cancer. The major problem reported with raloxifene is its poor bioavailability which is only up to 2%. The main objective of the present work was to formulate raloxifene loaded ethosomal preparation for transdermal application and compare it with an oral formulation of the drug. Five ethosomal formulations with different concentrations of ethanol and a conventional liposomes formulation were prepared by rotary evaporation method. The prepared systems were characterised by high resolution transmission electron microscopy (HRTEM), force emission electron microscopy (FESEM), atomic force microscopy (AFM), X-ray diffraction (XRD) and 31P NMR study. All these advanced characterization study established that the ethosome formulation was well defined by its size, shape and its bilayer formation. Transdermal flux of the optimized ethosome formulation was 22.14 ± 0.83 µg/ml/cm2 which was 21 times higher when compared to the conventional liposomes. Confocal microscopy study revealed an enhanced permeation of coumarin-6 dye loaded ethosomes to much deeper layers of skin when compared with conventional liposomes. The gel was found to be pseudoplastic with elastic behaviour. In-vivo studies on rats showed a higher bioavailability of RXL (157% times) for ethosomal formulation when compared with the oral formulation. In conclusion, RXL loaded ethosomal formulation via transdermal route showed superior drug delivery properties as compared to oral formulation. © 2018 Elsevier B.V.
format Article
author Mahmood, Syed
Mandal, Uttam Kumar
Chatterjee, Bappaditya
author_facet Mahmood, Syed
Mandal, Uttam Kumar
Chatterjee, Bappaditya
author_sort Mahmood, Syed
title Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
title_short Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
title_full Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
title_fullStr Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
title_full_unstemmed Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
title_sort transdermal delivery of raloxifene hcl via ethosomal system: formulation, advanced characterizations and pharmacokinetic evaluation
publisher Elsevier B.V.
publishDate 2018
url http://irep.iium.edu.my/63349/
http://irep.iium.edu.my/63349/
http://irep.iium.edu.my/63349/
http://irep.iium.edu.my/63349/1/63349_Transdermal%20delivery%20of%20raloxifene%20HCl.pdf
http://irep.iium.edu.my/63349/2/63349_Transdermal%20delivery%20of%20raloxifene%20HCl_SCOPUS.pdf
http://irep.iium.edu.my/63349/13/63349_Transdermal%20delivery%20of%20raloxifene%20HCl_WOS.pdf
first_indexed 2023-09-18T21:29:51Z
last_indexed 2023-09-18T21:29:51Z
_version_ 1777412438003548160